GovChime
Notice ID: dd0956db23454b0681616832cd8f5096SolicitationArchived

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

Archived on September 5, 2026. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
1:00 PM CDT
Posted
March 11, 2026
Notice type
Solicitation
Agency
Department of WarDEFENSE HEALTH AGENCY (DHA)

Notice details

Office
DEFENSE HEALTH AGENCY
Place of performance
San Antonio, Texas, 78230
Last updated
Nov 3, 2026
First published
Last updated on SAM.gov

Identifiers

Solicitation number
HT9402-26-Q-9202
Notice ID
dd0956db23454b0681616832cd8f5096

Description

The Department of War (DoW) is required by law (10 U.S.C. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoW Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoW Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ.

P&T COMMITTEE MEETING: The following May 2026 drug classes/subclass or newly approved drugs will be reviewed:

a.  Cardamyst - Calcium Channel Blocking Agents - NA
b. Myqorzo -  Cardiovascular Agents Miscellaneous - NA
c. Ontralfy - Skeletal Muscle Relaxants and Combinations - NA
d. Pivya - Antibiotics - Beta-lactams
e. Sdamlo - Calcium Channel Blocking Agents - NA
f. Vybrique - Phosphodiesterase-5 Inhibitors - Erectile Dysfunction
g. Zycubo - Electrolyte-Mineral-Trace Element Replacement - NA

The RFQ, including UF BPA and UF ADP appendices are attached here in. The instructions, important deadlines, and points of contact are in document, RFQ HT9402-26-Q-9202.

Pre-quotation teleconference is on March 11, 2026. Details are stated in Part 2.4. Pre-Quotation Teleconference. Responses to the clinical questions in Part 3.4 shall be submitted via e-mail to the RFQ POC in Part 2.3.1., no later than the date stated in Part 2.3.2.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

Files (10)

  • RFQ HT9402-26-Q-9202 NAD.pdf

    2.4 MBAdded in Solicitation version 1Posted
    Download
  • Price List - Cardamyst - Calcium Channel Blocking Agents - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Myqorzo - Cardiovascular Agents Miscellaneous - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Ontralfy - Skeletal Muscle Relaxants and Combinations - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Pivya -Antibiotics - Beta-lactams.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Sdamlo - Calcium Channel Blocking Agents - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Vybrique - Phosphodiesterase-5 Inhibitors - Erectile Dysfunction.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price List - Zycubo - Electrolyte-Mineral-Trace Element Replacement - NA.xlsx

    47 KBAdded in Solicitation version 1Posted
    Download
  • Price Appendix FAQ NAD.pdf

    231 KBAdded in Solicitation version 1Posted
    Download
  • DoD Formulary Placement of FDA Newly Approved Drugs.pdf

    83 KBAdded in Solicitation version 1Posted
    Download

Lifecycle

  1. 1
    Version 1SolicitationArchived

    Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

    Notice bc21eb281be04db5939621849299c76a on SAM.gov

  2. 3
    Version 3SolicitationArchivedCurrent

    Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program

    Notice dd0956db23454b0681616832cd8f5096 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

HT9402-26-Q-9202

Archive Date

Sep 5, 2026

Office Address

AURORA, CO, 80011